In Vitro N-Glycan Mannosyl-Phosphorylation of a Therapeutic Enzyme by Using Recombinant Mnn14 Produced from Pichia pastoris.
-
Purified soluble recombinant Mnn14 is itself catalytic: it converts the Man8GlcNAc2 acceptor into mono- and bis-mannosyl-phosphorylated products in vitro. This establishes an intrinsic mannosylphosphate transferase activity for MNN14, not merely a requirement for the pathway.
"Four recombinant enzymes (rMnn1447-935, rMnn1447-935-H6, rMnn1477-935-H6, and rMnn1477-935) converted the Man8GlcNAc2 glycan to the mono-mannosyl-phosphorylated (ManP-Man8GlcNAc2) and bis-mannosyl-phosphorylated forms (Man2P2-Man8GlcNAc2)"
-
The reaction uses GDP-mannose as the mannosyl-phosphate donor and a high-mannose N-glycan as acceptor, and is divalent-cation dependent with Mn2+ the preferred ion - consistent with the DXD motif and the LicD/fukutin-related fold.
"Among various metal ions (MnCl2, MgCl2, CaCl2, FeCl3, CuSO4, and ZnSO4) examined at 10 mM with regard to their effect on the enzyme activity of rMnn1477-935, MnCl2 was found to be best, and its optimal concentration was determined to be 10 mM"
-
Mnn14 acts on physiological high-mannose N-glycans on a real glycoprotein substrate: 74% of the Man7-9GlcNAc2 glycans of recombinant human lysosomal alpha-glucosidase were mannosyl-phosphorylated, mostly to the bis-phosphorylated form.
"Notably, 74% of the Man7-9GlcNAc2 glycans were mannosyl-phosphorylated by the in vitro reaction using rMnn1477-935"
-
Mnn14 is described as one of the main mannosyl-phosphorylation enzymes (MPEs) of S. cerevisiae, based on the companion gene-disruption and complementation work.
"the main MPEs in Saccharomyces cerevisiae"